HAL9000

Amazon in the green, deserves earnings exposure.

Long
HAL9000 Updated   
NASDAQ:AMZN   Amazon.com
GREAT LONG-TERM TECHNICAL PICTURE, SOME RECENT WEAKNESS
- Long term uptrend took us to historical high on October 6, 2016
- Gentle uptrend over the past 6 months with a breakout late Sept.
- Some short term weakness since the top, but still in breakout mode

SOLID, PRICEY FUNDAMENTALS
- Continues to impress the investment community
- 87.5% of consensus has a buy recommendation
- Consensus target price $913/Share (+11.6%)
- Justified by impressive long term EPS growth (+48.5%)
- Improving profitability (ROE 13.64%)
- Expensive stock (P/E 203.89x and P/BV 28.8x)

EXCITING EARNINGS PUBLICATION HISTORY: VOLATILE
- Over the past 13 quarters since mid-2013
- Measured the 5-day performance before and into earnings
- Average stock performance during earnings week = +2.60%
- Min -9.94% Max +20.00%

TRADING STRATEGY: USE OPTIONS FOR EXPOSURE
- Sell Nov 18'16 $750 put = +$9.33
- Buy Nov 18'16 $850 call = -$19.00
- Total cost = $9.67 (1.18%)
- Best case: Continuation of breakout ==> Make money on both legs
- Worst case: Stock falls post earnings and you become long a great story 8% below the current price.
Comment:
The stock is now down more than 10% since the inception of this idea against a flat/up market. Sell one more put on the Dec 16 '16 maturity with a lower, $700 strike and cash in nearly $10/share in premium. This makes the strategy a 0-cost one. Worst-case scenario if exercised is to be long 200 shares of AMZN at $725 against a strong support at $700/share. Risk is also staggered over 2 monthly options maturities so minimal.
Comment:
$700/share corresponds to the support from the previous top reached on Dec 29 2015 ($696.44) and to the 38.2% Fibonacci retracement from the top of the move initiated in Feb 2016. To this extent, after the recent vertical downfall and underperformance, it makes sense to bet on a rebound on the 700 support, if we get there.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.